Order ZstatFlu®.
		1. Glezen WP, Couch WP: Influenza viruses. P. 419. In Evans AS (ed): Viral Infections of Humans: Epidemiology and Control. 3rd Ed. Plenum, New York, 1989. 2. Kohn MA, Farley TA, Sundin D et al: Three summertime outbreaks of influenza type A. J Infect Dis 172:246, 1995. 3. Baker WH: Excess pneumonia and influenza A associated hospitalization during influenza epidemics in the United States, 1970-78. Am J Public Health 76:761, 1986. 4. Perrotta DM, Decker M, Glezen WP: Acute respiratory disease hospitalizations as a measure of impact of epidemic influenza. Am J Epidemiol 122:468, 1985. 5. Glezen WP: Serious morbidity and mortality associated with influenza epidemics. Epidemiol Rev 4:25, 1982. 6. Frank AL, Taber LH, Wells CR et al: Patterns of shedding of myxoviruses and papamyxoviruses in children. J Infect Dis 144:433, 1981. 7. Hall CB, Douglas RG Jr, Geiman JM, Meagher MP: Viral shedding patterns of children with influenza B infection. J Infect Dis 140:610, 1979. 8. Abramson JS, Wheeler JG: Virus-induced neutrophil dysfunction: role in the pathogenesis of bacterial infections. Pediatr Infect Dis J 13:543, 1994. 9. Wright PF, Ross KB, Thompson J, Karzon DT Influenza A infections in young children. N Engl J Med 296:829, 1977. 10. Puck JM, Glezen WP, Frank AL, Six HR: Protection of infants from infection with influenza A virus by transplacentally acquired antibody. J Infect Dis 42:844, 1980. 11. Serwint JR, Miller RM, Korsch BM: Influenza type A and B infections in hospitalized pediatric patients. Am J Dis Child 145:623, 1991. 12. Glezen WP, Paredes A, Tabler LH: Influenza in children. Relationship to other respiratory agents. JAMA 243:1345, 1980. 13. Kim HW, Brandt CD, Arrobio, JO et al: Influenza A and B virus infection in infants and young children during the years 1957-1976. Am J Epidemiol 109:464, 1979. 14. Liou Y-S, Barbour SD, Bell LM, Plotkin SA: Children hospitalized with influenza B infection. Pediatr Infect Dis J 6:541, 1987. 15. Laraya-Cuasay LR, Deforest A, Huff D et al: Chronic pulmonary complications of early influenza virus infection in children. Am Rev Respir Dis 116:617, 1977. 16. Kraemer MJ, Furukawa CT, Koup JR et al: Altered theophylline clearance during an influenza B outbreak. Pediatrics 69:476, 1982. 17. Feldman S, Webster RG, Sugg M: Influenza in childrren and young adults with cancer. Cancer 39:350, 1977. 18. Kempe A, Hall CB, MacDonald NE et al: Influenza in children with cancer. J Pediatr 115:33, 1989. 19. Ljungman P, Andersson J, Aschan J et al: Influenza A in immunocompromised patients. Clin Infect Dis 17:244, 1993. 20. Mauch TJ, Bratton S, Myers T et al: Influenza B virus infection in pediatric solid organ transplant recipients. Pediatrics 94:225, 1994. 21. Smith CB, Kanner RE, Golden CA et al: Effect of viral infections on pulmonary function in patients with chronic obstructive pulmonary diseases. J Infect Dis 141:271, 1980. 22. Sulkava R, Rissanen A, Pyhala R: Post-influenzal encephalitis during the influenza A outbreak in 1979/1980. J Neurol Neurosurg Psychiatry 44:161, 1981. 23. MacDonald KL, Osterholm MT, Hedberg CW et al: Toxic shock syndrome. A newly recognized complication of influenza and influenzalike illness. JAMA 257:1053, 1987. 24. Tolan RW Jr: Toxic shock syndrome complication influenza A in a child: case report and review. Clin Infect Dis 17:43, 1993. 25. Johnston SLG, Siegel CS: A comparison of direct immuno-fluorescence, shell vial culture, and convention cell culture for the rapid detection of influenza A and B. Diagn Microbiol Infect Dis 14:131, 1991. 26. Dominguez EA, Taber LH, Couch RB: Comparison of rapid diagnostic techniques for respiratory synyctial and influenza A virus respiratory infections in young children. J Clin Microbiol 31:2286, 1993. 27. Heikkinen T, Ruuskanen O, Waris M et al: Influenza vaccination in the prevention of acute otitis media in children. Am J Dis Child 145:445, 1991. 28. Gross PA, Lee H, Wolff JA et al: Influenza immunization in immunosuppressed children: J Pediatr 92:30, 1978. 29. Blumberg EA, Albano C, Pruett T et al: The immunogenicity of inflfuenza virus vaccine in solid organ transplant recipients. Clin Infect Dis 22:295, 1996. 30. Gruber WC, Campbell PW, Thompson JM et al: Comparison of live attenuted and inactivated influenza vaccines in cystic fibrosis and their families: results of a 3-year study. J Infect Dis 169:241, 1994. 31. Donnelly JJ, Friedman A, Martinez D et al: Preclinical efficacy of a prototype DNA vaccine: enhanced protection against antigenic drift in influenza virus. Nature Med 6:583, 1995. 32. Little JW, Hall WJ, Douglas RG Jr et al: Airway hyperreactivity and peripheral airway dysfunction in influenza A infection. Am Rev Respir Dis 118:295, 1978. 33. Hayden FG, Treanor JJ, Betts RF et al: Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza. JAMA 275:295, 1996. 34. Hayden FG: Combination antiviral therapy for respiratory virus infections. Antiviral Res. 29:45, 1996. 35. The MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group: Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. Lancet 352:1877, 1998.
			ZymeTx Web Sites: zymetx.com flu101.com fluwatch.com ©2003 - ZymeTx, Inc. ZstatFlu®, ViraZyme®, and ViraSTAT® are trademarks of ZymeTx, Inc.